Home » Topics » Regulatory » Patents

Patents
RSS

EGFR tyrosine kinase inhibitors described by Pfizer

Nov. 19, 1996

RPR claims taxoid antineoplastic compounds

Nov. 19, 1996

Growth stimulant reported by American Cyanamid

Nov. 19, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

Glaxo Wellcome claims 5alpha-reductase inhibitors for BPH

Nov. 19, 1996

Novo Nordisk claims immunosuppressive serine palmitoyl transferase inhibitors

Nov. 19, 1996

Lilly reports agents to treat menopause-related conditions

Nov. 15, 1996

PKC inhibitors from Lilly for various therapeutic indications

Nov. 15, 1996

Takeda describes potential antidiabetic agents

Nov. 15, 1996

New 5-HT3/5-HT4 antagonists from Synthelabo

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...